Detalles de la búsqueda
1.
Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.
Biochemistry
; 57(9): 1523-1532, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29412660
2.
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.
J Infect Dis
; 205(1): 28-34, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22090447
3.
Induction of homologous rather than heterologous antigen-specific CD4 T cell responses is critical for functional CD8 T cell responses in mice transgenic for a foreign antigen.
J Immunol
; 185(8): 4590-601, 2010 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20861346
4.
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.
Front Immunol
; 13: 1008764, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36159851
5.
CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity.
JCI Insight
; 7(11)2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35503656
6.
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
J Virol
; 83(10): 5192-203, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19279103
7.
Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics.
Antibodies (Basel)
; 8(3)2019 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31544852
8.
Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display.
J Microbiol Methods
; 62(3): 345-9, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15939494
9.
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.
Vaccine
; 30(37): 5533-40, 2012 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22749797
10.
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model.
PLoS One
; 6(8): e23791, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21876771
11.
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.
Vaccine
; 28(3): 650-6, 2010 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19896446
12.
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine.
Vaccine
; 28(12): 2397-407, 2010 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20060945
13.
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.
Vaccine
; 28(7): 1778-85, 2010 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-20018265
14.
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
PLoS One
; 5(8): e12217, 2010 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20808939
15.
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
PLoS One
; 5(2): e9349, 2010 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20186321
16.
Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis.
J Biol Chem
; 277(31): 27896-902, 2002 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-12023975
17.
Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.
Infect Immun
; 70(7): 3396-403, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12065478
18.
A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.
Infect Immun
; 70(11): 6494-8, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12379736
Resultados
1 -
18
de 18
1
Próxima >
>>